Literature DB >> 26260357

Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.

Frank H P Lai1, Ernie C F Lo2, Vesta C K Chan1, Mårten Brelen1, Wai Ling Lo1, Alvin L Young1.   

Abstract

The purpose of the study is to evaluate the surgical outcomes of combined pars plana vitrectomy-scleral buckle (PPV-SB) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy (PVR). One thousand one hundred and seventy four patients with rhegmatogenous retinal detachment surgery between January 2002 and December 2013 were retrospectively reviewed. Patients with grade C PVR treated with either combined PPV-SB or PPV alone were included in the study. Study outcomes included single surgery anatomic success rate and postoperative visual outcome at 12 months postoperatively. Seventy-seven patients with grade C PVR were identified for analysis. At the end of 12-month follow-up, 80.5 % eyes (33/41) in the PPV-SB group and 58.3 % eyes (21/36) in the PPV group achieved single surgery anatomical success. In a multiple logistic regression model, none of the baseline variables (age, gender, macula status, grade of PVR, extent of detachment, presence of vitreous hemorrhage, lens status, status of high myopia) nor types of retinal detachment surgery (use of scleral buckle, barrier endolaser, 360 degree endolaser, cryopexy, retinectomy, tamponade agent, phacoemulsification) had significant effect on single surgery anatomical success. The post-treatment mean logMAR visual acuity of the PPV-SB group was 1.58 ± 0.58 and the PPV group was 1.57 ± 0.61. There was no significant difference in the postoperative visual acuity between the two groups (P = 0.849). For patients with grade C PVR, PPV-SB did not demonstrate a superiority over PPV alone in achieving single surgery anatomical success.

Entities:  

Keywords:  Pars plana vitrectomy; Proliferative vitreoretinopathy; Retinal detachment; Scleral buckle

Mesh:

Year:  2015        PMID: 26260357     DOI: 10.1007/s10792-015-0104-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  28 in total

1.  Vitrectomy without scleral buckling for proliferative vitreoretinopathy.

Authors:  Tomohito Oyagi; Kazuyuki Emi
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

2.  Primary pars plana vitrectomy versus scleral buckle surgery for the treatment of pseudophakic retinal detachment: a randomized clinical trial.

Authors:  Periklis D Brazitikos; Sofia Androudi; William G Christen; Nikolaos Tr Stangos
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

3.  Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation--report no. 1.

Authors:  Hamid Ahmadieh; Siamak Moradian; Hooshang Faghihi; Mohammad M Parvaresh; Heshmatollah Ghanbari; Morsal Mehryar; Ebadollah Heidari; Hasan Behboudi; Touka Banaee; Banafsheh Golestan
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

4.  Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for secondary repair of retinal detachment.

Authors:  Ryan B Rush; Matthew P Simunovic; Saumil Sheth; Assaf Kratz; Alex P Hunyor
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2013-06-12       Impact factor: 1.300

Review 5.  Proliferative vitreoretinopathy: advances in surgical management.

Authors:  Robert E Coffee; Lai Jiang; Salman A Rahman
Journal:  Int Ophthalmol Clin       Date:  2014

6.  Scleral buckling procedures for longstanding or chronic rhegmatogenous retinal detachment with subretinal proliferation.

Authors:  Yi Yao; Li Jiang; Zhi-jun Wang; Mao-nian Zhang
Journal:  Ophthalmology       Date:  2006-05       Impact factor: 12.079

7.  Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group.

Authors:  M S Blumenkranz; S P Azen; T Aaberg; D C Boone; H Lewis; N Radtke; S J Ryan
Journal:  Am J Ophthalmol       Date:  1993-11-15       Impact factor: 5.258

8.  Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.

Authors:  Ron A Adelman; Aaron J Parnes; Jack O Sipperley; Didier Ducournau
Journal:  Ophthalmology       Date:  2013-04-17       Impact factor: 12.079

Review 9.  Pathophysiology of proliferative vitreoretinopathy in retinal detachment.

Authors:  Justus G Garweg; Christoph Tappeiner; Markus Halberstadt
Journal:  Surv Ophthalmol       Date:  2013-05-02       Impact factor: 6.048

10.  Surgical management of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled trials.

Authors:  Chetan Soni; Dean P Hainsworth; Arghavan Almony
Journal:  Ophthalmology       Date:  2013-03-16       Impact factor: 12.079

View more
  6 in total

Review 1.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

2.  Two-staged surgery as an alternative to buckle-vitrectomy for rhegmatogenous retinal detachment complicated by choroidal detachment.

Authors:  Naresh Babu; Piyush Kohli; Karthik Kumar; Renu P Rajan; Girish Baliga; Sagnik Sen; N O Ramachandran; S Bhavani; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2020-08-28       Impact factor: 2.031

3.  LYTAK1 attenuates proliferation of retinal pigment epithelial cells through TGF-β-mediated epithelial-mesenchymal transition via the ERK/AKT signaling pathway.

Authors:  Zhen Chen; Ninghua Ni; Yan Mei; Zhengrong Yang
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

4.  5-Fluorouracyl added infusion fluid in patients with recurrent rhegmatogeneous retinal detachment.

Authors:  Muharrem Karakaya; Sinan Albayrak; Seren Pehlivanoglu; Abdullah Ozkaya; Nur Acar Gocgil
Journal:  Saudi J Ophthalmol       Date:  2018-10-27

5.  Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy.

Authors:  Faruk Nisic; Nina Jovanovic; Milka Mavija; Emina Alimanovic-Halilovic; Aida Nisic; Orhan Lepara; Adem Cemerlic
Journal:  Arch Med Sci       Date:  2018-02-02       Impact factor: 3.318

6.  Knockdown of Fibromodulin Inhibits Proliferation and Migration of RPE Cell via the VEGFR2-AKT Pathway.

Authors:  He Hu; Shanshan Li; Jianqiao Li; Chao Huang; Fang Zhou; Li Zhao; Wenzhen Yu; Xiao Qin
Journal:  J Ophthalmol       Date:  2018-09-12       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.